Literature DB >> 17588712

Extracardiac ablation of the left ventricular septum in beating canine hearts using high-intensity focused ultrasound.

Ryo Otsuka1, Kana Fujikura, Yukio Abe, Kazue Okajima, Todd Pulerwitz, David J Engel, Robert Muratore, Jeffrey A Ketterling, Andrew Kalisz, Robert Sciacca, Charles Marboe, Genghua Yi, Jie Wang, Shunichi Homma.   

Abstract

BACKGROUND: High-intensity focused ultrasound (HIFU) produces immediate focal lesions without direct tissue contact. Previously, we reported the HIFU potential for cardiac ablation. The purpose of this study was to evaluate the possibility of myocardial ablation in the left ventricle of beating dog hearts with monitoring by 2-dimensional echocardiography.
METHODS: The operating frequency and the acoustic intensity were 5.25 MHz and 23 kW/cm(2), and the focal length and diameter were 3.3 mm axial and 0.37 mm wide at a distance of 35 mm from the transducer. Three dogs underwent a left-sided thoracotomy. The right ventricular surface was coupled with the transducer. The timing of the HIFU exposure was set during the early systolic phase using an electrocardiographic triggering system. The focal point was set in the left ventricular septum using 2-dimensional echocardiography mounted in the HIFU transducer. Ultrasound energy was delivered for 0.2 seconds. For each dog, we created 18 lesions. Exposures were performed 20, 30, or 40 times. Lesion size was assessed by manually measuring its length and width.
RESULTS: All lesions except one were clearly visible. The histologic lesion area was 18.7 +/- 8.3, 26.3 +/- 8.7, and 35.5 +/- 15.7 mm(2) (20, 30, and 40 times, respectively). The intraclass correlation coefficients were found to be 0.72, 0.63, 0.75, and 0.73 for lesion length, width, area, and depth, respectively.
CONCLUSION: HIFU can be used to create targeted, well-demarcated thermal lesions in the ventricular septum myocardium during cardiac contraction.

Entities:  

Mesh:

Year:  2007        PMID: 17588712     DOI: 10.1016/j.echo.2007.03.007

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  6 in total

1.  Characterization of macrolesions induced by myocardial cavitation-enabled therapy.

Authors:  Yiying I Zhu; Douglas L Miller; Chunyan Dou; Oliver D Kripfgans
Journal:  IEEE Trans Biomed Eng       Date:  2014-10-22       Impact factor: 4.538

2.  High-frequency ultrasound m-mode imaging for identifying lesion and bubble activity during high-intensity focused ultrasound ablation.

Authors:  Ronald E Kumon; Madhu S R Gudur; Yun Zhou; Cheri X Deng
Journal:  Ultrasound Med Biol       Date:  2012-02-15       Impact factor: 2.998

3.  Optimization of ultrasound parameters of myocardial cavitation microlesions for therapeutic application.

Authors:  Douglas L Miller; Chunyan Dou; Gabe E Owens; Oliver D Kripfgans
Journal:  Ultrasound Med Biol       Date:  2014-03-06       Impact factor: 2.998

4.  Use of Theranostic Strategies in Myocardial Cavitation-Enabled Therapy.

Authors:  Douglas L Miller; Chunyan Dou; Xiaofang Lu; Yiying I Zhu; Mario L Fabiilli; Gabe E Owens; Oliver D Kripfgans
Journal:  Ultrasound Med Biol       Date:  2015-04-15       Impact factor: 2.998

5.  Ultrasonic Cavitation-Enabled Treatment for Therapy of Hypertrophic Cardiomyopathy: Proof of Principle.

Authors:  Douglas L Miller; Xiaofang Lu; Chunyan Dou; Yiying I Zhu; Rachael Fuller; Kristina Fields; Mario L Fabiilli; Gabe E Owens; David Gordon; Oliver D Kripfgans
Journal:  Ultrasound Med Biol       Date:  2018-04-19       Impact factor: 2.998

6.  Noninvasive creation of an atrial septal defect by histotripsy in a canine model.

Authors:  Zhen Xu; Gabe Owens; David Gordon; Charles Cain; Achi Ludomirsky
Journal:  Circulation       Date:  2010-02-01       Impact factor: 29.690

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.